New Key Statistics Module, Z-Score and F-Score
NAS:PRME Key Ratios
| Market Cap $ M | 780.20 |
| Enterprise Value $ M | 664.28 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 3.20 |
| Price/Sales | 1,083.33 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | -- |
| EPS (TTM) $ | -2.18 |
| Beneish M-Score | 0 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -3.33 |
| EV-to-EBITDA | -3.41 |
| PEG | -- |
| Shares Outstanding M | 120.03 |
| Net Margin (%) | -34,601.86 |
| Operating Margin % | -33,773.27 |
| Pre-tax Margin (%) | -34,592.22 |
| Quick Ratio | 8.91 |
| Current Ratio | 8.91 |
| ROA % (ttm) | -76.18 |
| ROE % (ttm) | -93.83 |
| ROIC % (ttm) | -246.16 |
| Dividend Yield % | -- |
| Altman Z-Score | 3.54 |
PRME Number of Guru Trades
PRME Volume of Guru Trades
Gurus Latest Trades with NAS:PRME
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:PRME is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Prime Medicine Inc Insider Transactions
No Available Data
News about NAS:PRME
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers